Cancer BiologyFrontiers in OncologyPeer-reviewed
FOXI3 Promotes Migration and Proliferation in Prostate Cancer Bone Metastases, Modulated by FGF8.
Angana Mukherjee, Daniel P. Hollern, William A. Byrd…·Jacqueline Jones
DOI 10.3389/fonc.2026.1819598
Author
Clayton Clopton Yates
Johns Hopkins MedicineORCID 0000-0001-5420-9852Unclaimed ORCID profile · follow to get notified of new preprints
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2022-2026 · peak 2/yrCo-Author Collaboration Network
10 top collaborators · 15 mutual co-author linksFocal author (center)Selected co-authorORCID co-authorUnlinked name
Curved chords = mutual co-authorship2 shared papersGenetic & Genomic Medicine
Isra A. ElhussinORCID
Mutual co-authors in cluster
4 papers
Recent·Most cited
- Cancer BiologybioRxivPreprint
The MYC axis in advanced prostate cancer is impacted through concurrent targeting of ERβ and AR using a novel ERβ-selective ligand alongside Enzalutamide
Jaimie S. Gray, Sajad A. Wani, Shahid Hussain…·Moray J. Campbell
This study shows that combining a novel ERβ ligand with Enzalutamide reduces MYC signaling and growth in advanced prostate cancer.
4 citations - Genetic & Genomic MedicineCancer Research CommunicationsPeer-reviewed
Whole Exome Sequencing of Nigerian Prostate Tumors from the Prostate Cancer Transatlantic Consortium (CaPTC) Reveals DNA Repair Genes Associated with African Ancestry
Jason A. White, Ernest T. Kaninjing, Kayode Adebamiji Adeniji…·Clayton Clopton Yates
This study analyzes whole-exome sequencing data from Nigerian prostate cancer tumors to identify germline and somatic variants associated with African ancestry and DNA repair gene mutations.
26 citations - Molecular BiologybioRxivPreprint
Integrating pharmacogenomics data-driven prediction with bulk and single-cell RNAseq to demonstrate the efficacy of an NAMPT inhibitor against aggressive, taxane-resistant, and stem-like cells in lethal prostate cancer
Suman Mazumder, Taraswi Mitra Ghosh, Ujjal Kumar Mukherjee…·Amit Mitra
The paper uses scRNAseq and pharmacogenomics to identify FK866 as a potential drug for aggressive prostate cancer, showing its efficacy against drug-resistant and stem-like cells.
5 citations